Elsevier

Tuberculosis

Volume 121, March 2020, 101914
Tuberculosis

Review
The Many Hosts of Mycobacteria 8 (MHM8): A conference report

https://doi.org/10.1016/j.tube.2020.101914Get rights and content

Abstract

Mycobacteria are important causes of disease in human and animal hosts. Diseases caused by mycobacteria include leprosy, tuberculosis (TB), nontuberculous mycobacteria (NTM) infections and Buruli Ulcer. To better understand and treat mycobacterial disease, clinicians, veterinarians and scientists use a range of discipline-specific approaches to conduct basic and applied research, including conducting epidemiological surveys, patient studies, wildlife sampling, animal models, genetic studies and computational simulations. To foster the exchange of knowledge and collaboration across disciplines, the Many Hosts of Mycobacteria (MHM) conference series brings together clinical, veterinary and basic scientists who are dedicated to advancing mycobacterial disease research. Started in 2007, the MHM series recently held its 8th conference at the Albert Einstein College of Medicine (Bronx, NY). Here, we review the diseases discussed at MHM8 and summarize the presentations on research advances in leprosy, NTM and Buruli Ulcer, human and animal TB, mycobacterial disease comorbidities, mycobacterial genetics and ‘omics, and animal models. A mouse models workshop, which was held immediately after MHM8, is also summarized. In addition to being a resource for those who were unable to attend MHM8, we anticipate this review will provide a benchmark to gauge the progress of future research concerning mycobacteria and their many hosts.

Introduction

The 8th Many Hosts of Mycobacteria (MHM) conference was held at Albert Einstein College of Medicine (EINSTEIN) in Bronx, NY, March 4–6, 2019, for the purpose of identifying gaps in our collective knowledge of mycobacteria biology, mycobacteria-host interactions, mycobacterial disease surveillance and treatment. The Mycobacteria genus consists of ~200 bacterial species, a number of which cause significant diseases in numerous hosts (Fig. 1). The hosts of mycobacteria include humans and animals that are directly affected by the spectrum of infections caused by these pathogens, ranging from latent and asymptomatic to active and disease. Furthermore, lower eukaryotes are potential environmental reservoirs (e.g. amoeba, aquatic insects), higher eukaryotes facilitate zoonotic transmission (e.g. armadillo, deer), and inanimate materials are potential fomites or biofilm substrates (e.g. bronchoscopes, shower heads).

Since 2007, the MHM series has brought together basic, clinical and veterinary scientists with a shared interest in mycobacterial disease research. The workshop is held approximately every other year in a location of historical significance to those in this field. Previous MHM meetings have resulted in new collaborations, as well as a book that was authored by many of the meeting attendees [1]. The 2019 location (Albert Einstein College of Medicine, Bronx, NY) is significant to the field for its long history and reputation for making seminal advances in the fields of mycobacterial genetics, pathogenesis, and immunity. Participants in this year's conference were from eight different countries and represented universities, government agencies, academic medical centers, agricultural centers, zoos, and wildlife parks. Remarkably, and perhaps reflecting the worldwide distribution of pathogenic mycobacteria, the themes and challenges that were discussed at MHM8 were anything but country-specific.

Section snippets

Overview of the mycobacterial diseases discussed at MHM8

The mycobacterial diseases that were a focus of MHM8 included leprosy (M. leprae), Buruli Ulcer (M. ulcerans), other nontuberculous mycobacteria (NTM) infections, human tuberculosis (M. tuberculosis) (TB) and its associated comorbidities, as well as animal TB (M. bovis) in livestock, wildlife, and humans (zoonotic TB, zTB). An overview of these diseases was provided during the first MHM8 panel by Drs. Henry Boom (Case Western Reserve University), Kathryn Dupnik (Weill Cornell Medical College),

Advances in leprosy research

Recent advances in leprosy research that were made using the mouse and armadillo models, along with recent progress in the search for leprosy biomarkers, mechanisms of zoonotic transmission, and the discovery of a second leprosy-causing species (M. lepromatosis) were presented at MHM8. MHM8 speakers who were focused on these and other aspects of leprosy include Linda Adams (National Hansen's Disease Programs), Karen Dobos (Colorado State University), Maria Pena (National Hansen's Disease

Advances in nontuberculous mycobacteria and Buruli ulcer research

NTM are ubiquitous in outdoor environments (e.g. soil) and indoor environments (e.g. showerheads). This panel focused on two NTM that are present in environmental reservoirs and of growing clinical significance, Mycobacterium ulcerans and Mycobacterium abscessus. MHM8 speakers included Paul Converse and Eric Nuermberger (Johns Hopkins University), Alison Kraigsley (Center for Infectious Disease and Research, University of Minnesota), Luanne Hall-Stoodley (The Ohio State University), and Diane

Advances in human tuberculosis & immunology research

The importance of innate and adaptive immunity for mycobacterial disease resistance is well established. At MHM8, selected areas of progress and important remaining knowledge gaps in the immunology of infections with Mtb, NTM and other intracellular bacterial pathogens were presented and discussed. These included the roles of T cells (Steven Porcelli, Albert Einstein College of Medicine), B cells (John Chan, Albert Einstein College of Medicine), antibodies (Jacqueline Achkar, Albert Einstein

Advances in animal tuberculosis research

Animal TB is a global One Health issue, particularly in livestock and wildlife; multiple susceptible host species and infection with various members of the Mtb complex increase the complexity and potential impact of this disease in different ecosystems. The theme of complexity and lack of fundamental knowledge on disease burden, transmission dynamics, spillover and spillback between and within animal hosts, and inadequate diagnostic tests was repeatedly emphasized by the panel speakers: Peter

Mycobacterial disease comorbidities

Mycobacterial diseases do not exist in isolation; rather, they are often found with comorbidities that have developed before or after an initial mycobacterial infection event. Mycobacterial disease comorbidities are health conditions that originate independent of a mycobacterial disease (e.g. TB, leprosy), but exacerbate or worsen mycobacterial disease outcome or diagnosis. Comorbidities that were a focus of MHM8 included HIV/AIDS, adipose tissue loss, anti-helminthic therapy, and environmental

Advances in mycobacterial genetics

The increasing availability of population genomics and genetic data has allowed an improved understanding of genotypic differentiation among organisms, disease transmission dynamics, and vaccine development. The MHM8 speakers on this panel included Marcel Behr (McGill University, Canada), Liliana Salvador (University of Georgia, Georgia), John Spencer (Colorado State University, Colorado), Lief Kiresbom (Uppsala University, Sweden), and Bill Jacobs (Albert Einstein College of Medicine, New

Advances in mycobacterial ‘omics

Advancements in mycobacterial research include the incorporation of advanced methods, including the development of ‘omics approaches for understanding mycobacterial physiology, and provide fundamental knowledge that will improve the ability to advance research on interventions. At MHM8, the leading approaches to ‘omics data, including transcriptomics, metabolomics, lipidomics and proteomics were presented and discussed for mycobacteria, including Mtb and NTMs. Specific topics included the

Animal models of mycobacterial disease

Animal models of mycobacterial diseases have been essential to establishing our knowledge of mycobacterial disease pathogenesis and immunity and have provided directions for translational studies. The purpose of this panel discussion was to evaluate the strengths, limitations, and special considerations required when using different animal species for TB research. While the primary focus was on their suitability for Mtb translational research, models for M. bovis and M. marinum were also

Mouse models and imaging workshop

Mice are the most widely used animal model for studying host responses to TB and other mycobacterial diseases. The size, cost, genetic tractability, and availability of mouse-specific reagents all contribute to the attractiveness of using mice as a small animal model. Early studies that used mice predominantly relied on inbred laboratory strains including C57BL/6J mice. The mouse model workshop was organized by Igor Kramnik (Boston University, Massachusetts) as a follow up to a mouse model

Concluding remarks

The 2019 MHM8 meeting that was held at the Albert Einstein College of Medicine (EINSTEIN) in Bronx, NY, comprised presentations and ideation sessions by stakeholders working to advance research into leprosy, NTM/environmental mycobacteria infection, Buruli ulcer, human TB, animal TB, mycobacterial disease comorbidities, and animal models of mycobacterial disease. A workshop was also held to promote refinement of the mouse TB model, as mice remain the most widely used animal for in vivo testing.

Acknowledgements

The Many Hosts of Mycobacteria conference was supported by the National Institute of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grant 1R13AI145362-01. Presented work was further supported in part by funds from the NIH/NIAID (grants AI146329, AI127173, AI117927 to JMA; K23-AI131913 to KMD; AI121212 to RTR), as well as the USDA ARS and Oak Ridge Institute for Science and Education (to CK). The leprosy work presented by LBA was supported by an Interagency Agreement [

References (225)

  • Tuberculosis

    Leprosy and other mycobacterial diseases of man and animals: the many hosts of mycobacteria

    (2015)
  • Organization WH

    Global Leprosy Update, 2018: moving towards a leprosy-free world

    Wkly Epidemiol Rec

    (2019)
  • R. Sharma et al.

    Zoonotic leprosy in the southeastern United States

    Emerg Infect Dis

    (2015)
  • C. Avanzi et al.

    Red squirrels in the British Isles are infected with leprosy bacilli

    Science

    (2016)
  • S.E. Strollo et al.

    The burden of pulmonary nontuberculous mycobacterial disease in the United States

    Ann Am Thorac Soc

    (2015)
  • C. Vinnard et al.

    Deaths related to nontuberculous mycobacterial infections in the United States, 1999-2014

    Ann Am Thorac Soc

    (2016)
  • K.L. Winthrop et al.

    Incidence and prevalence of nontuberculous mycobacterial lung disease in a large United States managed care health plan, 2008-2015

    Ann Am Thorac Soc

    (2019)
  • D.R. Prevots et al.

    Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems

    Am J Respir Crit Care Med

    (2010)
  • K.L. Winthrop et al.

    Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease

    Am J Respir Crit Care Med

    (2010)
  • M.M. Jones et al.

    Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration

    PloS One

    (2018)
  • F.F. Pyarali et al.

    Increasing non-tuberculous mycobacteria infections in veterans with COPD and association with increased risk of mortality

    Front Med

    (2018)
  • M. Mirsaeidi et al.

    Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis

    Int J Infect Dis

    (2013)
  • K.N. Olivier et al.

    Nontuberculous Mycobacteria in Cystic Fibrosis Study G. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis

    Am J Respir Crit Care Med

    (2003)
  • J.R. Honda et al.

    Environmental nontuberculous mycobacteria in the Hawaiian islands

    PLoS Neglected Trop Dis

    (2016)
  • B.A. Brown-Elliott et al.

    Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies

    J Clin Microbiol

    (2011)
  • R. Chadha et al.

    An outbreak of post-surgical wound infections due to Mycobacterium abscessus

    Pediatr Surg Int

    (1998)
  • C.R. O'Brien et al.

    Clinical, microbiological and pathological findings of Mycobacterium ulcerans infection in three Australian Possum species

    PLoS Neglected Trop Dis

    (2014)
  • A. Mve-Obiang et al.

    Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence

    Infect Immun

    (2003)
  • W.R. Waters et al.

    Mycobacterium bovis infection of cattle and white-tailed deer: translational research of relevance to human tuberculosis

    ILAR J

    (2015)
  • O. Courtenay et al.

    Is Mycobacterium bovis in the environment important for the persistence of bovine tuberculosis?

    Biol Lett

    (2006)
  • A.E. Fine et al.

    A study of the persistence of Mycobacterium bovis in the environment under natural weather conditions in Michigan, USA

    Vet Med Int

    (2011)
  • E. Barbier et al.

    Impact of temperature and soil type on Mycobacterium bovis survival in the environment

    PloS One

    (2017)
  • R. Ghodbane et al.

    Long-term survival of tuberculosis complex mycobacteria in soil

    Microbiology

    (2014)
  • A. Sanchez-Hidalgo et al.

    Mycobacterium bovis hosted by free-living-amoebae permits their long-term persistence survival outside of host mammalian cells and remain capable of transmitting disease to mice

    Environ Microbiol

    (2017)
  • L. Yang et al.

    Evaluation of MIRU-VNTR for typing of Mycobacterium bovis isolated from Sika deer in Northeast China

    BMC Vet Res

    (2015)
  • R.L. Higgitt et al.

    Mycobacterium bovis infection in african wild dogs, Kruger national park, South Africa

    Emerg Infect Dis

    (2019)
  • S. Gagneux

    Host-pathogen coevolution in human tuberculosis

    Philos Trans R Soc Lond B Biol Sci

    (2012)
  • J.D. Ernst

    The immunological life cycle of tuberculosis

    Nat Rev Immunol

    (2012)
  • M.J. Blaser et al.

    The equilibria that allow bacterial persistence in human hosts

    Nature

    (2007)
  • C.A. Madigan et al.

    A zebrafish model of Mycobacterium leprae granulomatous infection

    J Infect Dis

    (2017)
  • M.H. Hazbon et al.

    Mycobacterial biomaterials and resources for researchers

    Pathog Dis

    (2018)
  • R.W. Truman et al.

    The armadillo as a model for peripheral neuropathy in leprosy

    ILAR J

    (2014)
  • R. Sharma et al.

    The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases

    Dis Model Mech

    (2013)
  • M.S. Duthie et al.

    LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection

    NPJ Vaccine

    (2018)
  • F.M. Amorim et al.

    Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum

    PLoS Neglected Trop Dis

    (2019)
  • M.B. da Silva et al.

    Evidence of zoonotic leprosy in Para, Brazilian Amazon, and risks associated with human contact or consumption of armadillos

    PLoS Neglected Trop Dis

    (2018)
  • X.Y. Han et al.

    A new Mycobacterium species causing diffuse lepromatous leprosy

    Am J Clin Pathol

    (2008)
  • R. Sharma et al.

    Isolation of Mycobacterium lepromatosis and development of molecular diagnostic assays to distinguish M. leprae and M. lepromatosis.

    Clin Infect Dis

    (2019)
  • P. Singh et al.

    Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis

    Proc Natl Acad Sci U S A

    (2015)
  • T.P. Stinear et al.

    Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans

    J Bacteriol

    (2005)
  • Cited by (4)

    • IL12RB1 allele bias in human T<inf>H</inf> cells is regulated by functional SNPs in its 3′UTR

      2022, Cytokine
      Citation Excerpt :

      Among TH cell genes affected by allele bias, we have focused on IL12RB1 due to its importance for early control of mycobacterial disease [14]. Mycobacterial disease is an important cause of global morbidity and mortality, varying in etiology and incidence depending on the geographical location [56]. Resistance to mycobacterial diseases is not controlled by a single gene or a single pathway; it is, however, heavily influenced by 14 autosomal genes (IL12RB1, IL12RB2, IL23R, IL12B, IFNG, IFNGR1, IFNGR2, STAT1, IRF8, SPPL2A, RORC, ISG15, TYK2, JAK1) and 2 X-linked genes (CYBB, NEMO) that are collectively referred to as the Mendelian susceptibility to mycobacterial disease (MSMD) gene family [3,57].

    View full text